Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
NMTC 
Neuroone Medical Technologies Corp (NMTC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: NMTC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -66.06% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 27.84M USD | Price to earnings Ratio - | 1Y Target Price 3.15 |
Price to earnings Ratio - | 1Y Target Price 3.15 | ||
Volume (30-day avg) 175792 | Beta 0.65 | 52 Weeks Range 0.55 - 1.39 | Updated Date 03/27/2025 |
52 Weeks Range 0.55 - 1.39 | Updated Date 03/27/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.27 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -125.02% | Operating Margin (TTM) 52.26% |
Management Effectiveness
Return on Assets (TTM) -68.86% | Return on Equity (TTM) -195.5% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 26366200 | Price to Sales(TTM) 4.84 |
Enterprise Value 26366200 | Price to Sales(TTM) 4.84 | ||
Enterprise Value to Revenue 4.59 | Enterprise Value to EBITDA -2.1 | Shares Outstanding 30862500 | Shares Floating 25169638 |
Shares Outstanding 30862500 | Shares Floating 25169638 | ||
Percent Insiders 24 | Percent Institutions 16.68 |
Analyst Ratings
Rating - | Target Price 3.15 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Neuroone Medical Technologies Corp
Company Overview
History and Background
NeuroOne Medical Technologies Corporation is a medical technology company focused on developing and commercializing innovative electrode technology for neural interface applications. The company was founded in 2015.
Core Business Areas
- Thin Film Electrode Technology: Development and manufacturing of thin film electrode arrays for various neural applications.
Leadership and Structure
The company is led by its CEO. The organizational structure consists of research and development, manufacturing, and commercialization teams.
Top Products and Market Share
Key Offerings
- evo Cortical Electrode: This product is a high-definition thin-film electrode array intended for use in minimally invasive surgical procedures for recording and stimulation of the brain. No significant market share data available due to early stage. Competitors: Ad-Tech Medical, Integra LifeSciences
Market Dynamics
Industry Overview
The neural interface market is experiencing growth driven by advancements in neurotechnology and increasing demand for therapies for neurological disorders.
Positioning
NeuroOne is positioning itself as a provider of advanced thin film electrode technology. Competitive advantages may include electrode density and material properties.
Total Addressable Market (TAM)
The TAM for neural interfaces is projected to reach billions of dollars. NeuroOne is positioned to capture a portion of this market with its innovative electrode technology.
Upturn SWOT Analysis
Strengths
- Innovative Electrode Technology
- Minimally Invasive Approach
- Potential for High-Definition Recording
Weaknesses
- Limited Commercial History
- Dependence on Regulatory Approvals
- Limited Financial Resources
Opportunities
- Expansion into New Neurological Applications
- Partnerships with Medical Device Companies
- Increasing Demand for Neurotechnology
Threats
- Competition from Established Medical Device Companies
- Regulatory Hurdles
- Technological Advancements by Competitors
Competitors and Market Share
Key Competitors
- ADTK
- IART
Competitive Landscape
NeuroOne faces competition from established medical device companies with greater resources and broader product portfolios. NeuroOne's competitive advantage lies in its innovative thin film electrode technology.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited given the company's relatively recent founding.
Future Projections: Future growth is dependent on successful product commercialization and regulatory approvals.
Recent Initiatives: Recent initiatives include clinical studies and development of new electrode configurations.
Summary
NeuroOne Medical Technologies Corp is an early-stage medical technology company with innovative electrode technology. The company's potential lies in its ability to commercialize its products and secure regulatory approvals. Challenges include competition from established players and limited financial resources. Success depends on continued innovation and strategic partnerships.
Similar Companies
- ADTK
- IART
Sources and Disclaimers
Data Sources:
- Company Website
- Market Research Reports
- Analyst Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may vary. The AI-based rating is based on publicly available information and should be interpreted with caution.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Neuroone Medical Technologies Corp
Exchange NASDAQ | Headquaters Eden Prairie, MN, United States | ||
IPO Launch date 2017-09-18 | President, CEO & Director Mr. David A. Rosa M.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 17 | Website https://nmtc1.com |
Full time employees 17 | Website https://nmtc1.com | ||
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.